Friday, July 10, 2026

pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma

Kyowa Kirin International

KYOWA KIRIN AUSTRALIA is a pharma organization headquartered in AU. Primary therapeutic focus areas include Aplastic Anemia, Advanced Hepatocellular Carcinoma, Advanced or Recurrent Breast Cancer, Moderate to Severe Plaq

GB HQ
1995 Founded
690 Employees
TGA registrant Type
Company details
Status
Public
HQ
GB
Founded
1995
Employees
690
Programs
15
Drugs
12
Patents
0
Clinical program

Placebo

Phase 1 · small molecule · Healthy Volunteers Essential Hypertension

Placebo for Healthy Volunteers Essential Hypertension is a Phase 1 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).

Internal code 3910-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
KYOWA KIRIN AUSTRALIA PTY LTD
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers Essential Hypertension
Status
active
Trials
1

Clinical trials